In ovarian cancer cells, platelet-derived TGF-β increased the invasive potential of tumor cells and induced EMT by increasing the phosphorylation of SMAD Family Member 2 (Smad2) (116). This evidence concerns the gene SMAD2 and ovarian cancer.